AGBC Público

The global pet insurance market is witnessing strong expansion, underpinned by growing pet ownership, rising veterinary costs, and increasing consumer awareness of pet welfare. In 2024, the market was valued in the tens of billions of USD; through the forecast period, it is expected to grow at a compound annual growth rate (CAGR) in the range of 15‑18%, reaching upwards of USD 40‑50+ billion by the early 2030s.

Market Segmentation & Share Highlights:

• Coverage types such as accident & illness dominate, capturing the majority of premium revenues. Owners favour plans that cover not only emergencies but chronic or hereditary conditions.

• Among animal types, dogs continue to account for the largest share, given their higher frequency of veterinary interventions; however, cats and “other pets” (exotics, small mammals, etc.) are registering faster growth rates.

• As for distribution channels, direct sales (online platforms, insurer websites) and “embedded insurance” (via pet‑supplies retailers, veterinary clinics, etc.) are gaining ground rapidly. Brokers…

The Education Smart Display market is witnessing steady growth, driven by rising demand for interactive learning environments, hybrid classrooms, and improved technological infrastructure. Valued at approximately USD 3.40 billion in 2024, the market is forecast to reach around USD 4.62 billion by 2032, growing at a compound annual growth rate (CAGR) of about 3.9% over the period.

Key segments influencing market dynamics include product type (whiteboards vs. video walls), display size (above 55" vs. up to 55"), display technologies (LCD, direct‑view LED, OLED), and resolution tiers (HD, FHD, 4K and higher). In 2024, the whiteboard segment held a dominant revenue share, due to its widespread adoption in traditional classrooms and training settings. Meanwhile, large‑screen formats above 55" also accounted for a significant portion of revenue.

Geographically, Europe led the global market in 2024, supported by advanced educational infrastructure and strong adoption of digital teaching aids. However, Asia‑Pacific is projected as the fastest‑growing region over the…

The global psychedelic drugs market is experiencing a significant surge, driven by growing demand for innovative mental health treatments. Valued at approximately USD 3.07 billion in 2024, the market is projected to reach USD 8.33 billion by 2032, expanding at a CAGR of 13.3%. This growth is fuelled by rising prevalence of depression, anxiety, PTSD, and other psychiatric disorders that conventional treatments fail to address effectively.

Key trends shaping the market include increasing acceptance of psychedelic-assisted therapies, ongoing clinical trials, and supportive regulatory designations. Substances such as psilocybin, MDMA, ketamine, and LSD are gaining attention for their therapeutic potential, especially in treatment-resistant cases.

The market is segmented by drug type, source (synthetic vs. natural), route of administration, and distribution channels. Hospitals and specialty clinics remain dominant end-users, while online pharmacies are gaining traction. North America leads the market due to progressive research and regulatory frameworks, while Asia-Pacific emerges as the fastest-growing region.